APO Research
Talk to an analyst

APO RESEARCH · REPORT

Viral Conjunctivitis Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Viral Conjunctivitis Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025180 pages

Choose your research edition.

Industry ResearchViral Conjunctivitis Drugs Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Viral Conjunctivitis Drugs Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Viral Conjunctivitis Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Viral Conjunctivitis Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Viral Conjunctivitis Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Viral Conjunctivitis Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Viral Conjunctivitis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Viral Conjunctivitis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Viral Conjunctivitis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Viral Conjunctivitis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Viral Conjunctivitis Drugs include Takeda, Novartis, Panoptes Pharma, NovaBay Pharmaceuticals, NicOx, NanoViricides, Allergan and Adenovir Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Viral Conjunctivitis Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Viral Conjunctivitis Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Viral Conjunctivitis Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Viral Conjunctivitis Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Viral Conjunctivitis Drugs Segment by Company

Takeda

Novartis

Panoptes Pharma

NovaBay Pharmaceuticals

NicOx

NanoViricides

Allergan

Adenovir Pharma

Viral Conjunctivitis Drugs Segment by Type

FST-100

APD—209

Viral Conjunctivitis Drugs Segment by Application

Hospitals

ASCs

Others

Viral Conjunctivitis Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viral Conjunctivitis Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Viral Conjunctivitis Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viral Conjunctivitis Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Viral Conjunctivitis Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Viral Conjunctivitis Drugs industry.

Chapter 3: Detailed analysis of Viral Conjunctivitis Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Viral Conjunctivitis Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Viral Conjunctivitis Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of FST-100 Table 3. Key Players of APD—209 Table 4. Global Viral Conjunctivitis Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals Table 6. Key Players of ASCs Table 7. Key Players of Others Table 8. Global Viral Conjunctivitis Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Viral Conjunctivitis Drugs Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Viral Conjunctivitis Drugs Market Share by Region (2021-2026) Table 11. Global Viral Conjunctivitis Drugs Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Viral Conjunctivitis Drugs Market Share by Region (2027-2032) Table 13. Viral Conjunctivitis Drugs Industry Trends Table 14. Viral Conjunctivitis Drugs Industry Drivers Table 15. Viral Conjunctivitis Drugs Industry Opportunities and Challenges Table 16. Viral Conjunctivitis Drugs Industry Restraints Table 17. Global Viral Conjunctivitis Drugs Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Viral Conjunctivitis Drugs Revenue Market Share by Company (2021-2026) Table 19. Global Viral Conjunctivitis Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Viral Conjunctivitis Drugs Key Company Head Office and Area Served Table 21. Global Viral Conjunctivitis Drugs Company, Product Type & Application Table 22. Global Viral Conjunctivitis Drugs Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Viral Conjunctivitis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Viral Conjunctivitis Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Viral Conjunctivitis Drugs Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Viral Conjunctivitis Drugs Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Viral Conjunctivitis Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Viral Conjunctivitis Drugs Revenue Market Share by Type (2027-2032) Table 30. Global Viral Conjunctivitis Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Viral Conjunctivitis Drugs Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Viral Conjunctivitis Drugs Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Viral Conjunctivitis Drugs Revenue Market Share by Application (2021-2026) Table 34. Global Viral Conjunctivitis Drugs Revenue Market Share by Application (2027-2032) Table 35. Takeda Company Information Table 36. Takeda Business Overview Table 37. Takeda Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Takeda Viral Conjunctivitis Drugs Product Portfolio Table 39. Takeda Recent Development Table 40. Novartis Company Information Table 41. Novartis Business Overview Table 42. Novartis Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Novartis Viral Conjunctivitis Drugs Product Portfolio Table 44. Novartis Recent Development Table 45. Panoptes Pharma Company Information Table 46. Panoptes Pharma Business Overview Table 47. Panoptes Pharma Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Panoptes Pharma Viral Conjunctivitis Drugs Product Portfolio Table 49. Panoptes Pharma Recent Development Table 50. NovaBay Pharmaceuticals Company Information Table 51. NovaBay Pharmaceuticals Business Overview Table 52. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Product Portfolio Table 54. NovaBay Pharmaceuticals Recent Development Table 55. NicOx Company Information Table 56. NicOx Business Overview Table 57. NicOx Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. NicOx Viral Conjunctivitis Drugs Product Portfolio Table 59. NicOx Recent Development Table 60. NanoViricides Company Information Table 61. NanoViricides Business Overview Table 62. NanoViricides Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. NanoViricides Viral Conjunctivitis Drugs Product Portfolio Table 64. NanoViricides Recent Development Table 65. Allergan Company Information Table 66. Allergan Business Overview Table 67. Allergan Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Allergan Viral Conjunctivitis Drugs Product Portfolio Table 69. Allergan Recent Development Table 70. Adenovir Pharma Company Information Table 71. Adenovir Pharma Business Overview Table 72. Adenovir Pharma Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Adenovir Pharma Viral Conjunctivitis Drugs Product Portfolio Table 74. Adenovir Pharma Recent Development Table 75. North America Viral Conjunctivitis Drugs Market Size by Type (2021-2026) & (US$ Million) Table 76. North America Viral Conjunctivitis Drugs Market Size by Type (2027-2032) & (US$ Million) Table 77. North America Viral Conjunctivitis Drugs Market Size by Application (2021-2026) & (US$ Million) Table 78. North America Viral Conjunctivitis Drugs Market Size by Application (2027-2032) & (US$ Million) Table 79. North America Viral Conjunctivitis Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Viral Conjunctivitis Drugs Market Size by Country (2021-2026) Table 81. North America Viral Conjunctivitis Drugs Market Size by Country (2027-2032) Table 82. Europe Viral Conjunctivitis Drugs Market Size by Type (2021-2026) & (US$ Million) Table 83. Europe Viral Conjunctivitis Drugs Market Size by Type (2027-2032) & (US$ Million) Table 84. Europe Viral Conjunctivitis Drugs Market Size by Application (2021-2026) & (US$ Million) Table 85. Europe Viral Conjunctivitis Drugs Market Size by Application (2027-2032) & (US$ Million) Table 86. Europe Viral Conjunctivitis Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe Viral Conjunctivitis Drugs Market Size by Country (2021-2026) Table 88. Europe Viral Conjunctivitis Drugs Market Size by Country (2027-2032) Table 89. China Viral Conjunctivitis Drugs Market Size by Type (2021-2026) & (US$ Million) Table 90. China Viral Conjunctivitis Drugs Market Size by Type (2027-2032) & (US$ Million) Table 91. China Viral Conjunctivitis Drugs Market Size by Application (2021-2026) & (US$ Million) Table 92. China Viral Conjunctivitis Drugs Market Size by Application (2027-2032) & (US$ Million) Table 93. Asia Viral Conjunctivitis Drugs Market Size by Type (2021-2026) & (US$ Million) Table 94. Asia Viral Conjunctivitis Drugs Market Size by Type (2027-2032) & (US$ Million) Table 95. Asia Viral Conjunctivitis Drugs Market Size by Application (2021-2026) & (US$ Million) Table 96. Asia Viral Conjunctivitis Drugs Market Size by Application (2027-2032) & (US$ Million) Table 97. Asia Viral Conjunctivitis Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia Viral Conjunctivitis Drugs Market Size by Country (2021-2026) Table 99. Asia Viral Conjunctivitis Drugs Market Size by Country (2027-2032) Table 100. South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Type (2021-2026) & (US$ Million) Table 101. South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Type (2027-2032) & (US$ Million) Table 102. South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Application (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Application (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Country (2021-2026) Table 106. South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Country (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Viral Conjunctivitis Drugs Product Image Figure 2. Global Viral Conjunctivitis Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Viral Conjunctivitis Drugs Market Share by Type: 2025 VS 2032 Figure 4. FST-100 Image Figure 5. APD—209 Image Figure 6. Global Viral Conjunctivitis Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Viral Conjunctivitis Drugs Market Share by Application: 2025 VS 2032 Figure 8. Hospitals Image Figure 9. ASCs Image Figure 10. Others Image Figure 11. Global Viral Conjunctivitis Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 13. Global Viral Conjunctivitis Drugs Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Viral Conjunctivitis Drugs Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Viral Conjunctivitis Drugs Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Viral Conjunctivitis Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Viral Conjunctivitis Drugs Revenue Market Share by Type (2021-2032) Figure 20. Global Viral Conjunctivitis Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Viral Conjunctivitis Drugs Revenue Market Share by Application (2021-2032) Figure 22. North America Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 23. North America Viral Conjunctivitis Drugs Market Share by Type (2021-2032) Figure 24. North America Viral Conjunctivitis Drugs Market Share by Application (2021-2032) Figure 25. North America Viral Conjunctivitis Drugs Market Share by Country (2021-2032) Figure 26. United States Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 27. Canada Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 29. Europe Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Europe Viral Conjunctivitis Drugs Market Share by Type (2021-2032) Figure 31. Europe Viral Conjunctivitis Drugs Market Share by Application (2021-2032) Figure 32. Europe Viral Conjunctivitis Drugs Market Share by Country (2021-2032) Figure 33. Germany Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 34. France Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 36. Italy Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 37. Russia Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 39. China Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 40. China Viral Conjunctivitis Drugs Market Share by Type (2021-2032) Figure 41. China Viral Conjunctivitis Drugs Market Share by Application (2021-2032) Figure 42. Asia Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 43. Asia Viral Conjunctivitis Drugs Market Share by Type (2021-2032) Figure 44. Asia Viral Conjunctivitis Drugs Market Share by Application (2021-2032) Figure 45. Asia Viral Conjunctivitis Drugs Market Share by Country (2021-2032) Figure 46. Japan Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 50. India Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 51. Australia Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Viral Conjunctivitis Drugs Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Viral Conjunctivitis Drugs Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Viral Conjunctivitis Drugs Market Share by Country (2021-2032) Figure 56. Brazil Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 61. UAE Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 63. Chile Viral Conjunctivitis Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • FST-100
  • APD—209
Applications
  • Hospitals
  • ASCs
  • Others
Companies covered
  • Takeda
  • Novartis
  • Panoptes Pharma
  • NovaBay Pharmaceuticals
  • NicOx
  • NanoViricides
  • Allergan
  • Adenovir Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Viral Conjunctivitis Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 FST-100
  5. 1.2.3 APD—209
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Viral Conjunctivitis Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 ASCs
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Viral Conjunctivitis Drugs Growth Trends by Region
  13. 1.5.1 Global Viral Conjunctivitis Drugs Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Viral Conjunctivitis Drugs Market Size by Region (2021-2026)
  15. 1.5.3 Viral Conjunctivitis Drugs Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Viral Conjunctivitis Drugs Market Dynamics
  1. 2.1 Viral Conjunctivitis Drugs Industry Trends
  2. 2.2 Viral Conjunctivitis Drugs Industry Drivers
  3. 2.3 Viral Conjunctivitis Drugs Industry Opportunities and Challenges
  4. 2.4 Viral Conjunctivitis Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Viral Conjunctivitis Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Viral Conjunctivitis Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Viral Conjunctivitis Drugs Key Company Head office and Area Served
  4. 3.4 Global Viral Conjunctivitis Drugs Company, Product Type & Application
  5. 3.5 Global Viral Conjunctivitis Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Viral Conjunctivitis Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Viral Conjunctivitis Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Viral Conjunctivitis Drugs Tier 1, Tier 2, and Tier 3
4 Viral Conjunctivitis Drugs Market by Type
  1. 4.1 Global Viral Conjunctivitis Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Viral Conjunctivitis Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Viral Conjunctivitis Drugs Market Size Share by Type (2021-2032)
5 Viral Conjunctivitis Drugs Market by Application
  1. 5.1 Global Viral Conjunctivitis Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Viral Conjunctivitis Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Viral Conjunctivitis Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Viral Conjunctivitis Drugs Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis Viral Conjunctivitis Drugs Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Panoptes Pharma
  14. 6.3.1 Panoptes Pharma Company Information
  15. 6.3.2 Panoptes Pharma Business Overview
  16. 6.3.3 Panoptes Pharma Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Panoptes Pharma Viral Conjunctivitis Drugs Product Portfolio
  18. 6.3.5 Panoptes Pharma Recent Developments
  19. 6.4 NovaBay Pharmaceuticals
  20. 6.4.1 NovaBay Pharmaceuticals Company Information
  21. 6.4.2 NovaBay Pharmaceuticals Business Overview
  22. 6.4.3 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Product Portfolio
  24. 6.4.5 NovaBay Pharmaceuticals Recent Developments
  25. 6.5 NicOx
  26. 6.5.1 NicOx Company Information
  27. 6.5.2 NicOx Business Overview
  28. 6.5.3 NicOx Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 NicOx Viral Conjunctivitis Drugs Product Portfolio
  30. 6.5.5 NicOx Recent Developments
  31. 6.6 NanoViricides
  32. 6.6.1 NanoViricides Company Information
  33. 6.6.2 NanoViricides Business Overview
  34. 6.6.3 NanoViricides Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 NanoViricides Viral Conjunctivitis Drugs Product Portfolio
  36. 6.6.5 NanoViricides Recent Developments
  37. 6.7 Allergan
  38. 6.7.1 Allergan Company Information
  39. 6.7.2 Allergan Business Overview
  40. 6.7.3 Allergan Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Allergan Viral Conjunctivitis Drugs Product Portfolio
  42. 6.7.5 Allergan Recent Developments
  43. 6.8 Adenovir Pharma
  44. 6.8.1 Adenovir Pharma Company Information
  45. 6.8.2 Adenovir Pharma Business Overview
  46. 6.8.3 Adenovir Pharma Viral Conjunctivitis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Adenovir Pharma Viral Conjunctivitis Drugs Product Portfolio
  48. 6.8.5 Adenovir Pharma Recent Developments
7 North America
  1. 7.1 North America Viral Conjunctivitis Drugs Market Size (2021-2032)
  2. 7.2 North America Viral Conjunctivitis Drugs Market Size by Type
  3. 7.2.1 North America Viral Conjunctivitis Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Viral Conjunctivitis Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Viral Conjunctivitis Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Viral Conjunctivitis Drugs Market Size by Application
  7. 7.3.1 North America Viral Conjunctivitis Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Viral Conjunctivitis Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Viral Conjunctivitis Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Viral Conjunctivitis Drugs Market Size by Country
  11. 7.4.1 North America Viral Conjunctivitis Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Viral Conjunctivitis Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Viral Conjunctivitis Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Viral Conjunctivitis Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Viral Conjunctivitis Drugs Market Size (2021-2032)
  2. 8.2 Europe Viral Conjunctivitis Drugs Market Size by Type
  3. 8.2.1 Europe Viral Conjunctivitis Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Viral Conjunctivitis Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Viral Conjunctivitis Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Viral Conjunctivitis Drugs Market Size by Application
  7. 8.3.1 Europe Viral Conjunctivitis Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Viral Conjunctivitis Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Viral Conjunctivitis Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Viral Conjunctivitis Drugs Market Size by Country
  11. 8.4.1 Europe Viral Conjunctivitis Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Viral Conjunctivitis Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Viral Conjunctivitis Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Viral Conjunctivitis Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Viral Conjunctivitis Drugs Market Size (2021-2032)
  2. 9.2 China Viral Conjunctivitis Drugs Market Size by Type
  3. 9.2.1 China Viral Conjunctivitis Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Viral Conjunctivitis Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Viral Conjunctivitis Drugs Market Share by Type (2021-2032)
  6. 9.3 China Viral Conjunctivitis Drugs Market Size by Application
  7. 9.3.1 China Viral Conjunctivitis Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Viral Conjunctivitis Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Viral Conjunctivitis Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Viral Conjunctivitis Drugs Market Size (2021-2032)
  2. 10.2 Asia Viral Conjunctivitis Drugs Market Size by Type
  3. 10.2.1 Asia Viral Conjunctivitis Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Viral Conjunctivitis Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Viral Conjunctivitis Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Viral Conjunctivitis Drugs Market Size by Application
  7. 10.3.1 Asia Viral Conjunctivitis Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Viral Conjunctivitis Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Viral Conjunctivitis Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Viral Conjunctivitis Drugs Market Size by Country
  11. 10.4.1 Asia Viral Conjunctivitis Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Viral Conjunctivitis Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Viral Conjunctivitis Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Viral Conjunctivitis Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Viral Conjunctivitis Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Viral Conjunctivitis Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Viral Conjunctivitis Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Viral Conjunctivitis Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst